ACCÈS RAPIDE AUX LIENS
The glyoxal pathway plays a role in the detoxification of glucose degradation products (GDP). Glyoxalase I and Gyloxalase II (also designated hydroxyacyl glutathione hydrolase or HAGH) are members of the Gyloxalase family. The Gyloxalase II enzyme is a thiolesterase that catalyzes the hydrolysis of S-D-lactoyl-glutathione to form reduced glutathione and D-lactic acid. It exists only as a monomer and binds two zinc ions per subunit. Glyoxalase II contains 260 amino acids. It is detected in the mitochondria and cytosol of mammals. Both Glyoxalase I and Gyloxalase II are detected at a higher activity level in breast cancer tissues than with matched unaffected tissues. This suggests that glyoxalase inhibitor drugs may be effective in the treatment of cancer.
Informations pour la commande
Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps Glyoxalase II (C-6) | sc-271663 | 200 µg/ml | $316.00 | |||
Glyoxalase II (C-6): m-IgG Fc BP-HRP Kit | sc-537676 | 200 µg Ab; 10 µg BP | $354.00 | |||
Glyoxalase II (C-6): m-IgGκ BP-HRP Kit | sc-535017 | 200 µg Ab; 40 µg BP | $354.00 | |||
Glyoxalase II (C-6): m-IgG1 BP-HRP Kit | sc-545300 | 200 µg Ab; 20 µg BP | $354.00 | |||
Glyoxalase II (C-6) peptide neutralisant | sc-271663 P | 100 µg/0.5 ml | $68.00 |